Alzheimer’s – www.brainwork.md

22nd June 2022

Journal watch: Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

https://www.brainwork.md/content/uploads/2022/06/Brainwork-Journal-watch-Microglial-activation-states-drive-glucose-uptake-and-FDG-PET-alterations-in-neurodegenerative-diseases.jpg 850 567 Shawn Haigh Shawn Haigh https://secure.gravatar.com/avatar/d4448de12cafdc782da0f7b369642f0e?s=96&d=mm&r=g 22nd June 2022 22nd June 2022

The Background 2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) is a commonly used method to detect regional reductions in brain glucose uptake typically observed in patients with Alzheimer’s disease (AD) and other…

Shawn Haigh
0
0

29th May 2020

Optimising early diagnosis of Alzheimer’s disease – mission impossible?

https://www.brainwork.md/content/uploads/2020/05/MPR761-KSA-Brainwork-2020-EAN-EM-V00-02-20200529_article-1-e1590764532778.jpg 1920 1080 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 29th May 2020 2nd June 2020

Alzheimer’s disease (AD) is a very common malady of the elderly, currently affecting 5.8 million Americans above the age of 65. It accounts for 60–80% of all dementia cases, which…

Anna Stelling, PhD
0
0